TransCode Therapeutics last closed at $1.78 (+1.14%) on 2026-10-06. Signals today: RSI rebound. Listed on Nasdaq. Trailing 12 months PER is -0.0×. Its overall grade ranks 702 of 741 stocks in Healthcare.
About this company
TransCode Therapeutics last closed at $1.78 (+1.14%) on 2026-10-06. Signals today: RSI rebound. Listed on Nasdaq.
Details →Reported results
Details →
Position in sector
Healthcare · Overall F · 702/741
Valuation grade C+
Related stocks
- RocheCustomer
RNA 치료제/종양 분야에서 임상·라이선스 협력 가능성이 큰 글로벌 제약사
- NovartisCompetitor
종양·RNA 기반 혁신치료제 개발 경쟁군에 속하는 대형 제약사
- PfizerCompetitor
항암제 및 핵산/유전자 치료제 분야의 대형 경쟁사
About TransCode Therapeutics
- What technical signals does TransCode Therapeutics (RNAZ) have?
- TransCode Therapeutics current technical signals: RSI rebound.
- Is TransCode Therapeutics a cup-and-handle pattern?
- No. TransCode Therapeutics has no valid Cup signal right now.
- What published figures are available for TransCode Therapeutics?
- Market cap: $1.63M. Trailing 12 months PER: -0.0×. Latest quarter PBR: 0.01×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Turn what you saw on this name into a strategy
Ask Q about TransCode Therapeutics, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.
Quantus Signal · live data · not investment advice · Privacy Policy